LIFECORE BIOMEDICAL, INC. Inventory Write-down
LIFECORE BIOMEDICAL, INC. (LFCR) reported Inventory Write-down of $1.22 million for the 3-month period ending 2024-08-25, per its 10-Q filed 2024-10-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2024-10-04
- LIFECORE BIOMEDICAL, INC. inventory write-down for the quarter ending 2024-08-25 was $1.22M, a 69.58% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. inventory write-down for the quarter ending 2024-05-26 was -$324.00K.
- LIFECORE BIOMEDICAL, INC. inventory write-down for the quarter ending 2024-02-25 was -$2.00M.
- LIFECORE BIOMEDICAL, INC. inventory write-down for the quarter ending 2023-11-26 was -$900.00K.
- LIFECORE BIOMEDICAL, INC. inventory write-down for fiscal 2023 was $4.90M, a 6.52% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. inventory write-down for fiscal 2022 was $4.60M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|
| 2024-08-25 | $1.22M 10-Q · filed 2024-10-04 | $893.00K derived: sum of 2 quarters · filed 2024-10-04 | -$1.11M derived: sum of 3 quarters · filed 2024-10-04 | -$2.01M derived: sum of 4 quarters · filed 2024-10-04 | |
| 2024-05-26 | -$324.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2024-10-04 | -$2.32M derived: sum of 2 quarters · filed 2024-10-04 | -$3.22M derived: sum of 3 quarters · filed 2024-10-04 | $776.00K 10-Q · filed 2024-10-04 | $800.00K 10-K · filed 2024-08-26 |
| 2024-02-25 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | -$2.90M derived: sum of 2 quarters · filed 2024-08-09 | $1.10M 10-Q · filed 2024-08-09 | ||
| 2023-11-26 | -$900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $3.10M 10-Q · filed 2024-08-09 | |||
| 2023-08-27 | $4.00M 10-Q · filed 2024-08-09 | ||||
| 2023-05-28 | $4.90M 10-K · filed 2024-08-26 | ||||
| 2022-05-29 | $4.60M 10-K · filed 2024-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |